Yu Takahashi Hideaki Wakita Takuma Ishihara Hideto Okazaki Akihiro Ito Mitsunaga Iwata Shigeru Sonoda Yohei Doi
10.1016/j.jiac.2022.08.025
J Infect Chemother
2023 Jan;29(1):95-97.
covid-19 drug therapy p r remdesivir alliative care ehabilitation
NO-CC CODE
https://pubmed.ncbi.nlm.nih.gov/36113848/
COVID-19 Drug Treatment
COVID-19 Drug Treatment Review Aged Alanine / adverse effects Alanine / therapeutic use Antiviral Agents Delivery of Health Care Hospitals Humans SARS-CoV-2 remdesivir Antiviral Agents Alanine
PMC9472478
36113848
Short-course remdesivir for healthcare-associated COVID-19: Case series from a non-acute care hospital
2023